Kim Jong Un compares Trump’s speech to declaration of war, vows tough responseWorld September 22, 7:20
US move to quit Iran nuclear deal to send wrong signal to North Korea — Russia’s UN envoyWorld September 22, 6:39
Moscow welcomes reform of UN’s anti-terrorism activities — LavrovRussian Politics & Diplomacy September 22, 3:53
NATO seeking to revive cold war-era climate — LavrovRussian Politics & Diplomacy September 22, 3:51
Situation in Syria gives grounds for cautious optimism — LavrovWorld September 22, 1:24
NATO secretary general comments on Russian military drillsWorld September 21, 21:34
NATO secretary general hails idea of deploying UN force in UkraineWorld September 21, 21:29
Russia ready to discuss alternative resolutions on UN mission to DonbassRussian Politics & Diplomacy September 21, 20:18
UN approves probe into Islamic State crimes in IraqWorld September 21, 20:10
NOVOSIBIRSK, June 9. /TASS/. A new vaccine to protect against Ebola virus disease developed by Russia’s Vector research center of virology and biotechnology has successfully undergone the first stage of clinical tests, the acting director general of the research center told reporters on the sidelines of the international forum for technological development on Thursday.
"The first phase of clinical tests has been completed. It is now on approval at the Russian Ministry of Healthcare. We are waiting for a second phase," Valery Mikheyev said.
According to the World Health Organization (WHO), more than 11,300 people have died from Ebola in West Africa, primarily in Guinea, Sierra Leone and Liberia. More than 28,600 were infected. In January, Russia informed the WHO executive committee about its anti-Ebola vaccines.
The World Health Organization describes Ebola virus disease (formerly known as Ebola haemorrhagic fever) as "a severe, often fatal illness, with a case fatality rate of up to 90%." Until now, there has been no known cure or vaccine for the disease. The only treatment offered is "supportive intensive care." During an outbreak, those at higher risk of infection are health workers, family members and others in close contact with sick people and deceased patients.